SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | VERTEX PHARMACEUTICALS INC / MA | 22,281,729 | 8.6% | EDGAR |
SC 13G/A | 2024-02-09 | FMR LLC | VERTEX PHARMACEUTICALS INC / MA | 12,981,286 | 5.0% | EDGAR |
SC 13G/A | 2024-02-09 | Capital World Investors | VERTEX PHARMACEUTICALS INC / MA | 22,080,207 | 8.6% | EDGAR |
SC 13G | 2024-01-25 | BlackRock Inc. | VERTEX PHARMACEUTICALS INC / MA | 21,881,203 | 8.5% | EDGAR |
SC 13D/A | 2023-06-05 | VERTEX PHARMACEUTICALS INC / MA | Kymera Therapeutics, Inc. | 0 | 0.0% | EDGAR |
SC 13G | 2023-02-13 | Capital World Investors | VERTEX PHARMACEUTICALS INC / MA | 12,939,319 | 5.0% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | VERTEX PHARMACEUTICALS INC / MA | 21,546,903 | 8.4% | EDGAR |
SC 13G | 2023-02-09 | FMR LLC | VERTEX PHARMACEUTICALS INC / MA | 17,876,774 | 7.0% | EDGAR |
SC 13G | 2023-01-24 | BlackRock Inc. | VERTEX PHARMACEUTICALS INC / MA | 24,241,437 | 9.4% | EDGAR |
SC 13G/A | 2022-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | VERTEX PHARMACEUTICALS INC / MA | 5,421,291 | 2.1% | EDGAR |
SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | VERTEX PHARMACEUTICALS INC / MA | 20,155,842 | 7.9% | EDGAR |
SC 13G/A | 2022-02-09 | FMR LLC | VERTEX PHARMACEUTICALS INC / MA | 9,233,569 | 3.6% | EDGAR |
SC 13G/A | 2022-02-01 | BlackRock Inc. | VERTEX PHARMACEUTICALS INC / MA | 23,944,931 | 9.4% | EDGAR |
SC 13G/A | 2021-02-16 | PRICE T ROWE ASSOCIATES INC /MD/ | VERTEX PHARMACEUTICALS INC / MA | 19,626,208 | 7.5% | EDGAR |
SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | VERTEX PHARMACEUTICALS INC / MA | 20,433,050 | 7.9% | EDGAR |
SC 13G/A | 2021-02-08 | FMR LLC | VERTEX PHARMACEUTICALS INC / MA | 13,506,870 | 5.2% | EDGAR |
SC 13G/A | 2021-02-01 | BlackRock Inc. | VERTEX PHARMACEUTICALS INC / MA | 24,268,895 | 9.3% | EDGAR |
SC 13D | 2020-09-03 | VERTEX PHARMACEUTICALS INC / MA | Kymera Therapeutics, Inc. | 3,151,121 | 7.1% | EDGAR |
SC 13G/A | 2020-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | VERTEX PHARMACEUTICALS INC / MA | 24,525,905 | 9.5% | EDGAR |
SC 13G/A | 2020-02-13 | VERTEX PHARMACEUTICALS INC / MA | CRISPR Therapeutics AG | 2,690,470 | 4.4% | EDGAR |